Bloomberg
AstraZeneca Is Said to Have Explored Bristol Myers Merger
Wednesday, August 5, 2026
AstraZeneca explored an acquisition of Bristol-Myers Squibb, Bloomberg reported, citing people familiar with the matter. A combined company would rank as the largest merger in pharmaceutical industry history by deal value. No announcement of a completed transaction or formal offer was reported.
